(Q34216239)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916573%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

meta-analysis

0 references

title

Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916573%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916573%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Michal Zikán

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916573%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Ladislav Dušek

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916573%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Ondrej Majek

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916573%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

1 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916573%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anticancer Therapy

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916573%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916573%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916573%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

1197-1207

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916573%20AND%20SRC:MED&resulttype=core&format=json

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls

12 February 2020

cites work

1 reference

Hormonal contraception and risk of cancer.

21 January 2018

1 reference

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

21 January 2018

1 reference

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives

21 January 2018

1 reference

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

21 January 2018

1 reference

Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study

21 January 2018

1 reference

Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.

21 January 2018

1 reference

Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States).

21 January 2018

1 reference

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2Mutation

21 January 2018

1 reference

Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group

21 January 2018

1 reference

Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: a systematic review

21 January 2018

1 reference

Reproductive issues for women with BRCA mutations

21 January 2018

1 reference

BRCA1 and BRCA2 germ-line mutations and oral contraceptives: to use or not to use.

21 January 2018

1 reference

Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing

21 January 2018

1 reference

BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.

21 January 2018

1 reference

Oral contraceptives and the risk of breast cancer.

21 January 2018

1 reference

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease

21 January 2018

1 reference

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group

21 January 2018

1 reference

Oral contraceptive use and BRCA penetrance: a case-only study

21 January 2018

1 reference

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.

21 January 2018

1 reference

Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study

21 January 2018

1 reference

Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations

21 January 2018

1 reference

Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis

21 January 2018

1 reference

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

21 January 2018

1 reference

Tubal ligation and the risk of ovarian cancer: review and meta-analysis

21 January 2018

1 reference

Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.

21 January 2018

1 reference

New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy

21 January 2018

1 reference

Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

21 January 2018

1 reference

Oral contraceptives, salpingo-oophorectomy and hormone replacement therapy in BRCA1–2 mutation carriers

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERA.11.38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21916573%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference